Sanofi and Regeneron report eosinophilic esophagiti trial data
Sanofi and Regeneron Pharmaceuticals have reported additional positive results from Part A of a Phase...
Sanofi and Translate Bio find positive preclinical Covid-19 vaccine results
Sanofi’s vaccines global business unit Sanofi Pasteur and Translate Bio have reported preclinical trial results...
Sanofi’s Kevzara misses endpoints in Phase III Covid-19 trial
Sanofi has reported that the Phase III clinical trial of Kevzara (sarilumab) performed outside the...
Sanofi reports positive results from nirsevimab in infants with RSV
Sanofi has reported that nirsevimab led to a significant decrease in medically attended lower respiratory...
Inotrem to initiate Phase IIa study of nangibotide for Covid-19
French biotechnology company Inotrem has received regulatory clearance to conduct a Phase IIa clinical trial...
Abivax doses first patient in Phase II/III Covid-19 clinical trial
French biotechnology company Abivax has dosed the first patient in its Phase II/III study of...
A closer look at Regeneron and its efforts to provide the world with a Covid-19 treatment
Having grown into one of the biggest companies in the biotech sphere since its inception...
Firms may find it ‘difficult’ to co-market combined Covid-19 drugs, says analyst
Currently, one of the most prominent Covid-19 treatments being trialled is a combined approach involving...
Sanofi’s Sarclisa meets primary goal in multiple myeloma trial
Sanofi has reported positive data from the Phase III IKEMA clinical trial of Sarclisa (isatuximab)...
GSK-Sanofi alliance: are pharma partnerships key to ending Covid-19?
GSK and Sanofi announced an "unprecedented" partnership last month - with the goal of developing...